MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹1,705 Cr | ₹8.68 Cr | ₹48 Cr | ₹16 Cr | ₹-36 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MANKIND PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹1,705 Cr |
Mar2024 | ₹8.68 Cr |
Mar2023 | ₹48 Cr |
Mar2022 | ₹16 Cr |
Mar2021 | ₹-36 Cr |
How is Deferred Tax Assets / Liabilities of MANKIND PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹1,705 Cr | 19,538.48 | |
Mar2024 | ₹8.68 Cr | -81.74 | |
Mar2023 | ₹48 Cr | 191.02 | |
Mar2022 | ₹16 Cr | Positive | |
Mar2021 | ₹-36 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹107,691.3 Cr | 1.7% | 5.8% | 6.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,370.0 Cr | 0.7% | 0.4% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,087.0 Cr | -1.7% | 2% | 16.7% | Stock Analytics | |
CIPLA | ₹126,308.0 Cr | -0.9% | 5.3% | -3.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,614.0 Cr | -0.1% | 0.6% | 6.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,845.0 Cr | 4.1% | 7.6% | -3% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 1.7% |
5.8% |
6.8% |
SENSEX | 1.1% |
1% |
-0.9% |
You may also like the below Video Courses